Arteriotomy Closure Devices - Medical Devices Pipeline Assessment, 2017

Publisher Name :
Date: 01-Aug-2017
No. of pages: 79
Inquire Before Buying

Arteriotomy Closure Devices - Medical Devices Pipeline Assessment, 2017

Summary

GlobalData's Medical Devices sector report, "Arteriotomy Closure Devices - Medical Devices Pipeline Assessment, 2017" provides an overview of Arteriotomy Closure Devices currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Arteriotomy Closure Devices pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Arteriotomy Closure Devices under development

- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities

- The report reviews the major players involved in the development of Arteriotomy Closure Devices and list all their pipeline projects

- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage

- The report provides key clinical trial data of ongoing trials specific to pipeline products

- Recent developments in the segment / industry

Reasons to buy

The report enables you to -

- Formulate significant competitor information, analysis, and insights to improve R&D strategies

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Identify and understand important and diverse types of Arteriotomy Closure Devices under development

- Develop market-entry and market expansion strategies

- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

- In-depth analysis of the product's current stage of development, territory and estimated launch date

Arteriotomy Closure Devices - Medical Devices Pipeline Assessment, 2017

Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 6
2 Introduction 7
2.1 Arteriotomy Closure Devices Overview 7
3 Products under Development 8
3.1 Arteriotomy Closure Devices - Pipeline Products by Stage of Development 8
3.2 Arteriotomy Closure Devices - Pipeline Products by Segment 9
3.3 Arteriotomy Closure Devices - Pipeline Products by Territory 10
3.4 Arteriotomy Closure Devices - Pipeline Products by Regulatory Path 11
3.5 Arteriotomy Closure Devices - Pipeline Products by Estimated Approval Date 12
3.6 Arteriotomy Closure Devices - Ongoing Clinical Trials 13
4 Arteriotomy Closure Devices - Pipeline Products under Development by Companies 14
4.1 Arteriotomy Closure Devices Companies - Pipeline Products by Stage of Development 14
4.2 Arteriotomy Closure Devices - Pipeline Products by Stage of Development 15
5 Arteriotomy Closure Devices Companies and Product Overview 16
5.1 Aporo Biomedical, Inc. (Inactive) Company Overview 16
5.1.1 Aporo Biomedical, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 16
5.2 Boston Scientific Corp Company Overview 17
5.2.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 17
5.3 CardioDex Ltd. Company Overview 27
5.3.1 CardioDex Ltd. Pipeline Products & Ongoing Clinical Trials Overview 27
5.4 CloSys Corp Company Overview 28
5.4.1 CloSys Corp Pipeline Products & Ongoing Clinical Trials Overview 28
5.5 Cook Medical Inc Company Overview 29
5.5.1 Cook Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 29
5.6 CPC of America Inc Company Overview 30
5.6.1 CPC of America Inc Pipeline Products & Ongoing Clinical Trials Overview 30
5.7 Essential Medical Inc Company Overview 31
5.7.1 Essential Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 31
5.8 Harvard University Company Overview 36
5.8.1 Harvard University Pipeline Products & Ongoing Clinical Trials Overview 36
5.9 Mayo Clinic US Company Overview 37
5.9.1 Mayo Clinic US Pipeline Products & Ongoing Clinical Trials Overview 37
5.10 ProMed, Inc. Company Overview 38
5.10.1 ProMed, Inc. Pipeline Products & Ongoing Clinical Trials Overview 38
5.11 Rex Medical LP Company Overview 39
5.11.1 Rex Medical LP Pipeline Products & Ongoing Clinical Trials Overview 39
5.12 Sheba Medical Center Company Overview 40
5.12.1 Sheba Medical Center Pipeline Products & Ongoing Clinical Trials Overview 40
5.13 Terumo Corp Company Overview 41
5.13.1 Terumo Corp Pipeline Products & Ongoing Clinical Trials Overview 41
5.14 Transluminal Technologies LLC Company Overview 42
5.14.1 Transluminal Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview 42
5.15 University of Rochester Company Overview 43
5.15.1 University of Rochester Pipeline Products & Ongoing Clinical Trials Overview 43
5.16 Vascular Closure Systems, Inc. Company Overview 44
5.16.1 Vascular Closure Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview 44
5.17 Vascular Solutions Inc Company Overview 47
5.17.1 Vascular Solutions Inc Pipeline Products & Ongoing Clinical Trials Overview 47
5.18 Vivasure Medical Ltd. Company Overview 48
5.18.1 Vivasure Medical Ltd. Pipeline Products & Ongoing Clinical Trials Overview 48
6 Arteriotomy Closure Devices- Recent Developments 51
6.1 May 12, 2017: Boston Scientific Announces Positive European Registry Results For WATCHMAN Left Atrial Appendage Closure Device 51
6.2 May 10, 2017: Boston Scientific to Present Data On WATCHMAN Left Atrial Appendage System at EuroPCR 2017 51
6.3 May 01, 2017: Cardinal Health Reports Third-quarter Results for Fiscal Year 2017 52
6.4 Apr 18, 2017: Cardinal Health updates fiscal 2017 guidance; Provides early outlook for future fiscal years 53
6.5 Mar 13, 2017: Cook Medical Announces Umesh Patel as President of Cook Biotech 54
6.6 Mar 07, 2017: Anteo Technologies Announces Verification Study With Cook Medical Australia 54
6.7 Feb 07, 2017: Cardinal Health Reports Second-quarter Results for Fiscal Year 2017 55
6.8 Jan 30, 2017: Memorial City Cardiology Associates Among First to Offer Breakthrough Atrial Fibrillation Treatment 56
6.9 Jan 09, 2017: Cardinal Health Reaches Settlement With West Virginia 57
6.10 Dec 23, 2016: Cardinal Health Announces Civil Settlement with DOJ 57
6.11 Dec 12, 2016: Essential Medical Announces the Successful Initiation of the U.S. MANTA Vascular Closure Device Trial With the First Patients Enrolled in TAVR and EVAR Cases 58
6.12 Nov 07, 2016: Essential Medical Announces Successful Live Case at TCT 59
6.13 Nov 02, 2016: Boston Scientific Announces Initial U.S. Commercial Performance Of The WATCHMAN Left Atrial Appendage Closure Device 59
6.14 Oct 31, 2016: Cardinal Health Reports First-quarter Results for Fiscal Year 2017 60
6.15 Oct 26, 2016: Vivasure Medical Appoints Robert Hance to Companys Board of Directors 61
6.16 Oct 24, 2016: Boston Scientific announced key Presentations on WATCHMAN Left Atrial Appendage System at Transcatheter Cardiovascular Therapeutics 2016 62
6.17 Oct 24, 2016: New study compares different approaches for stroke prevention in patients with non-valvular atrial fibrillation 63
6.18 Oct 24, 2016: Vascular Solutions Reports Third Quarter Results 64
6.19 Oct 19, 2016: St. Jude Medical Reports Third Quarter 2016 Results 67
6.20 Oct 11, 2016: SentreHEART Announces First Clinical Use of the Eclipse Surgical Left Atrial Appendage Closure Device 68
6.21 Sep 26, 2016: Jon Giacomin of Cardinal Health Elected Chairman of HDA Board of Directors 69
6.22 Aug 31, 2016: Rose Medical Center among First Hospitals in Colorado Offering Alternative to Long-Term Warfarin Medication with Newly Approved WATCHMAN LAAC Implant 69
6.23 Aug 31, 2016: Cook Medical Names Jean-Marc Creissel Vice President of Operations in Greater China 70
6.24 Aug 08, 2016: InSeal Medical Announces CE Mark Approval for the InClosure Large Bore Vascular Closure Device 70
6.25 Aug 02, 2016: Cardinal Health Reports Q4 And Fiscal 2016 Results, Provides Fiscal 2017 Outlook 71
6.26 Aug 01, 2016: Essential Medical Announces FDA Approval to Begin a U.S. Clinical Trial for the X-Seal 6F Vascular Closure Device 73
6.27 Jul 25, 2016: Vascular Solutions Reports Second Quarter Results 73
7 Appendix 76
7.1 Methodology 76
7.2 About GlobalData 79
7.3 Contact Us 79
7.4 Disclaimer 79

1.1 List of Tables
Table 1: Arteriotomy Closure Devices - Pipeline Products by Stage of Development 8
Table 2: Arteriotomy Closure Devices - Pipeline Products by Segment 9
Table 3: Arteriotomy Closure Devices - Pipeline Products by Territory 10
Table 4: Arteriotomy Closure Devices - Pipeline Products by Regulatory Path 11
Table 5: Arteriotomy Closure Devices - Pipeline Products by Estimated Approval Date 12
Table 6: Arteriotomy Closure Devices - Ongoing Clinical Trials 13
Table 7: Arteriotomy Closure Devices Companies - Pipeline Products by Stage of Development 14
Table 8: Arteriotomy Closure Devices - Pipeline Products by Stage of Development 15
Table 9: Aporo Biomedical, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 16
Table 10: Femoral Artery Closure Device - Product Status 16
Table 11: Femoral Artery Closure Device - Product Description 16
Table 12: Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 17
Table 13: WATCHMAN Left Atrial Appendage System - Product Status 17
Table 14: WATCHMAN Left Atrial Appendage System - Product Description 18
Table 15: Boston Scientific Corp - Ongoing Clinical Trials Overview 19
Table 16: WATCHMAN Left Atrial Appendage System - A Prospective, Multi-center, Pilot Study to Compare the Safety and Effectiveness of WATCHMAN Left Atrial Appendage Occlusion Device with Rivaroxaban for Stroke Prevention in Patients With Atrial Fibrillation 21
Table 17: WATCHMAN Left Atrial Appendage System - AMPLATZER Amulet Left Atrial Appendage Occluder Randomized Controlled Trial 21
Table 18: WATCHMAN Left Atrial Appendage System - Assessment of the Watchman Device in Patients Unsuitable for Oral Anticoagulation: ASAP-TOO 21
Table 19: WATCHMAN Left Atrial Appendage System - China Registry of WATCHMAN Left Atrial Appendage Closure for Non-valvular Atrial Fibrillation 22
Table 20: WATCHMAN Left Atrial Appendage System - Combined Transcatheter Aortic Valve Implantation and Percutaneous Closure of the Left Atrial Appendage 22
Table 21: WATCHMAN Left Atrial Appendage System - Comparison of Safety and Efficacy of Left Atrial Appendage Occlusion Devices 22
Table 22: WATCHMAN Left Atrial Appendage System - Continued Access To PREVAIL (CAP2)- Watchman Left Atrial Appendage (LAA) Closure Technology 23
Table 23: WATCHMAN Left Atrial Appendage System - Interventional Left Atrial Appendage Closure Vs. Novel Anticoagulation Agents in High-risk Patients with Atrial Fibrillation (PRAGUE-17 Study) 23
Table 24: WATCHMAN Left Atrial Appendage System - Left Atrial Appendage Closure Compared to Standard Antiplatelet Therapy in Patients With AF Who Underwent Percutaneous Coronary Intervention 23
Table 25: WATCHMAN Left Atrial Appendage System - Long Term Clinical Outcomes of Left Atrial Appendage Occlusion Versus New Oral Anticoagulants for Stroke Prevention in Patients with Non-valvular Atrial Fibrillation: From Korean Multicenter Registry 24
Table 26: WATCHMAN Left Atrial Appendage System - Registry on WATCHMAN Outcomes in Real-life Utilization 24
Table 27: WATCHMAN Left Atrial Appendage System - Registry on WATCHMAN Outcomes in Real-Life Utilization WASP Registry 24
Table 28: WATCHMAN Left Atrial Appendage System - The Evaluation of Thrombogenicity in Patients Undergoing WATCHMAN Left Atrial Appendage Closure Trial 25
Table 29: WATCHMAN Left Atrial Appendage System - The Strategy to Prevent Hemorrhage Associated with Anticoagulation in Renal Disease Management (STOP HARM) Trial 25
Table 30: WATCHMAN Left Atrial Appendage System - Watch Bleeding Episodes after Left Atrial Appendage Occlusion Versus Usual Care in Patients with Atrial FIBrillatIon and Severe to end-stage Chronic Kidney Disease (WatchAFIB in CKD) 25
Table 31: WATCHMAN Left Atrial Appendage System - WATCHMAN for Patients with Atrial Fibrillation Undergoing Transcatheter Aortic Valve Replacement 26
Table 32: CardioDex Ltd. Pipeline Products & Ongoing Clinical Trials Overview 27
Table 33: EpiClose Plus - Product Status 27
Table 34: EpiClose Plus - Product Description 27
Table 35: CloSys Corp Pipeline Products & Ongoing Clinical Trials Overview 28
Table 36: CloSys HD - Product Status 28
Table 37: CloSys HD - Product Description 28
Table 38: Cook Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 29
Table 39: X-Port Vascular Access Closure Device - Product Status 29
Table 40: X-Port Vascular Access Closure Device - Product Description 29
Table 41: CPC of America Inc Pipeline Products & Ongoing Clinical Trials Overview 30
Table 42: MedClose - Product Status 30
Table 43: MedClose - Product Description 30
Table 44: Essential Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 31
Table 45: MANTA - Product Status 31
Table 46: MANTA - Product Description 31
Table 47: X-Seal - Product Status 32
Table 48: X-Seal - Product Description 32
Table 49: Essential Medical Inc - Ongoing Clinical Trials Overview 33
Table 50: X-Seal - US Clinical Trial for the X-Seal 6F Vascular Closure Device 34
Table 51: MANTA - Pivotal Clinical Study to Evaluate the Safety and Effectiveness of MANTA Vascular Closure Device 35
Table 52: Harvard University Pipeline Products & Ongoing Clinical Trials Overview 36
Table 53: Access-Closure Device - Product Status 36
Table 54: Access-Closure Device - Product Description 36
Table 55: Mayo Clinic US Pipeline Products & Ongoing Clinical Trials Overview 37
Table 56: Left Atrial Appendage Closure Device - Product Status 37
Table 57: Left Atrial Appendage Closure Device - Product Description 37
Table 58: ProMed, Inc. Pipeline Products & Ongoing Clinical Trials Overview 38
Table 59: Large Hole Closure Device - Product Status 38
Table 60: Large Hole Closure Device - Product Description 38
Table 61: Rex Medical LP Pipeline Products & Ongoing Clinical Trials Overview 39
Table 62: Auto-Close Vascular Sealing System - Product Status 39
Table 63: Auto-Close Vascular Sealing System - Product Description 39
Table 64: Sheba Medical Center Pipeline Products & Ongoing Clinical Trials Overview 40
Table 65: Left Atrial Appendage Intraatrial Transcatheter Sutureless Closure - Product Status 40
Table 66: Left Atrial Appendage Intraatrial Transcatheter Sutureless Closure - Product Description 40
Table 67: Terumo Corp Pipeline Products & Ongoing Clinical Trials Overview 41
Table 68: Vascular Closure Device - Product Status 41
Table 69: Vascular Closure Device - Product Description 41
Table 70: Transluminal Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview 42
Table 71: Velox CD - Product Status 42
Table 72: Velox CD - Product Description 42
Table 73: University of Rochester Pipeline Products & Ongoing Clinical Trials Overview 43
Table 74: Vascular Closure Device - Product Status 43
Table 75: Vascular Closure Device - Product Description 43
Table 76: Vascular Closure Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview 44
Table 77: FastSeal Bioabsorbable Vascular Access Closure System - Product Status 44
Table 78: FastSeal Bioabsorbable Vascular Access Closure System - Product Description 44
Table 79: FastSeal Self - Closing Nitinol Clip System - Product Status 45
Table 80: FastSeal Self - Closing Nitinol Clip System - Product Description 45
Table 81: FastSeal Swellable And Bioabsorbable Tubular Plug System - Product Status 45
Table 82: FastSeal Swellable And Bioabsorbable Tubular Plug System - Product Description 46
Table 83: Vascular Solutions Inc Pipeline Products & Ongoing Clinical Trials Overview 47
Table 84: Magna Seal - Product Status 47
Table 85: Magna Seal - Product Description 47
Table 86: Vivasure Medical Ltd. Pipeline Products & Ongoing Clinical Trials Overview 48
Table 87: PerQseal - Product Status 48
Table 88: PerQseal - Product Description 48
Table 89: Vivasure Medical Ltd. - Ongoing Clinical Trials Overview 49
Table 90: PerQseal - Clinical Investigation Plan (CIP) for Safety and Performance Study of Large Hole Vascular Closure Device - FRONTIER III Study 50
Table 91: PerQseal - Safety and Performance Study of Large Hole Vascular Closure Device - FRONTIER II Study 50
Table 92: Glossary 78

1.2 List of Figures
Figure 1: Arteriotomy Closure Devices - Pipeline Products by Stage of Development 8
Figure 2: Arteriotomy Closure Devices - Pipeline Products by Segment 9
Figure 3: Arteriotomy Closure Devices - Pipeline Products by Territory 10
Figure 4: Arteriotomy Closure Devices - Pipeline Products by Regulatory Path 11
Figure 5: Arteriotomy Closure Devices - Pipeline Products by Estimated Approval Date 12
Figure 6: Arteriotomy Closure Devices - Ongoing Clinical Trials 13
  • Global Angiographic Catheter Market Professional Survey Report 2017
    Published: 16-Oct-2017        Price: US 3500 Onwards        Pages: 128
    This report studies Angiographic Catheter in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering - Terumo Medical - Abbott Vascular - Asahi - Boston Scientific C......
  • Global Wireless Electrocardiograph Market Research Report 2017
    Published: 16-Oct-2017        Price: US 2900 Onwards        Pages: 105
    In this report, the global Wireless Electrocardiograph market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Wireless Electrocardiograph in these regions, from 2012 to 2022 (forecast), covering - North America - Europe......
  • Global and Regional Heart Lung Machine Market Research Report 2017
    Published: 14-Oct-2017        Price: US 3500 Onwards        Pages: 123
    Summary Heart Lung Machine is a device used in open heart surgery to support the body during the surgical procedure while the heart is stopped. The heart-lung machine is often referred to as the "pump", and does the work of the heart and lungs during the operation. Market Segment as follows: By Region - Asia-Pacific - North America - Europe - South America - Middle East & Africa By Type - Single......
  • Global and Regional Heart Defect Closure Devices Market Research Report 2017
    Published: 14-Oct-2017        Price: US 3500 Onwards        Pages: 142
    Summary Heart defect closure devices are permanent implants designed to close defects between chambers of the heart or a patent ductus arteriosus. These are self-expandable, self-centering umbrella-like devices. The design and shape of the devices vary, as does their exact mode of deployment. They are implanted in the defect in a cardiac catheterization laboratory, through catheters inserted into either a vein or an artery (transcatheter or percutaneous approach). There are severa......
  • 2017-2022 North America Defibrillator Market Report
    Published: 13-Oct-2017        Price: US 4660 Onwards        Pages: 117
    "This report will be delivered in 2-3 business days after the order is placed."In 2016, the North America Defibrillator market size was xx million USD and it will reach xx million USD in 2022, with a CAGR of xx% between 2016 and 2022.This report studies Defibrillator in North America market, especially in United States, Canada and Mexico, focuses on the top players in each country, covering Medtronic St. Jude Medical Bo......
  • 2017-2022 China Defibrillator Market Report (Status and Outlook)
    Published: 13-Oct-2017        Price: US 3360 Onwards        Pages: 117
    "This report will be delivered in 2-3 business days after the order is placed."In 2016, the Defibrillator market size was xx million USD in China, and it will be xx million USD in 2022, with a CAGR of xx% between 2016 and 2022.In China market, the top players include Medtronic St. Jude Medical Boston Scientific Biotronik Sorin Group Philips Healthcare Cardiac Science ......
  • Asia-Pacific Artificial Heart Lung Machines Market by Manufacturers, Regions, Type and Application, Forecast to 2022
    Published: 13-Oct-2017        Price: US 4480 Onwards        Pages: 121
    Artificial Heart Lung Machines is a device used in open heart surgery to support the body during the surgical procedure while the heart is stopped. The heart-lung machine is often referred to as the "pump", and does the work of the heart and lungs during the operation. Scope of the Report: This report focuses on the Artificial Heart Lung Machines in Asia-Pacific market, especially in China, Japan, Korea, Taiwan, Southeast Asia, India and Australia. This report categorizes t......
  • 2017-2022 United States Defibrillator Market Report (Status and Outlook)
    Published: 13-Oct-2017        Price: US 3360 Onwards        Pages: 117
    "This report will be delivered in 2-3 business days after the order is placed."In 2016, the Defibrillator market size was xx million USD in United States, and it will be xx million USD in 2022, with a CAGR of xx% between 2016 and 2022.In United States market, the top players include Medtronic St. Jude Medical Boston Scientific Biotronik Sorin Group Philips Healthcare Cardiac S......
  • Global Vascular Closure Devices Market Research Report 2017
    Published: 13-Oct-2017        Price: US 2900 Onwards        Pages: 119
    In this report, the global Vascular Closure Devices market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Vascular Closure Devices in these regions, from 2012 to 2022 (forecast), covering - North America - Europe - ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs